News

Trump gives drugmakers 60 days to match U.S. prescription prices with lower international rates, aiming to cut costs for ...
The Lancet Haematology's Adverse Events Reporting Series scrutinises an overlooked aspect of clinical trials, emphasising ...
Antibody-drug conjugates are currently being investigated in more than 260 clinical trials.“It’s going to be the next novel ...
The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...
In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...
Ever since President Donald Trump started promising to slap tariffs on pharmaceutical imports, drugmakers have unveiled a ...
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...
On July 31, the Trump administration told 17 major drugmakers to align U.S. medication prices with the lowest prices sold in other countries, or the most-favored-nation price.  The White House ...
Experts are skeptical that Big Pharma companies will cut prices after President Donald Trump demands Most Favored Nation policies within 60 days.
From new payload linkers to artificial intelligence partnerships, advances in ADC pipelines push forward selective cancer therapies that minimize side effects.
SINGAPORE (Reuters) -Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent letters to major ...
As ever, big tech stocks like chipmakers Broadcom and Nvidia are providing the boost. PayPal has slumped as it saw total ...